Sunday, December 5, 2021
Home Tags Indian Pharma companies

Tag: Indian Pharma companies

Australia can be Major Partner for Indian Pharma Companies

India is one of the top ten sources of medicine for the Australian market under the pharmaceutical benefits scheme and is shifting...

Indian Pharma Cos at high ransomware attack risk in 2021

New Delhi: Targeted ransomware attacks on the healthcare and pharma sector will surge in India in 2021 as companies finalise their vaccines to fight C-19, a new report said...

Indian Pharma Cos to benefit from increasing demand in US: Report

New Delhi: Indian pharma companies are expected to benefit from improving demand in the US market, said India Ratings and Research (Ind-Ra). As...

Vaccine plans of Indian pharma industry

Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-C-19 formulations as the world's largest producer of vaccines...

The Biden effect on Indian Pharma Cos

The Biden effect on Indian Pharma Companies We expect there to be an even stronger focus on generics...

Foreign companies willing to tie-up with Indian pharma companies

Prime Minister Narendra Modi today asked Indian pharma companies, involved in making coronavirus vaccines, to give suggestions and ideas regarding the regulatory processes and...

Webinar for Indian and German pharma firms on Nov 27: Pharmexcil

The Pharmexcil in association with Consulate General of India in Frankfurt, Germany and Chamber of Commerce (IHK) Frankfurt is organizing a one-day...

Indian Pharma Cos recall various products in US market

New Delhi: Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the...

Opportunities for Indian drug exporters from Serbia

The southeast European country, Serbia which is referred to as the crossroad of Europe due to its position in the central Balkan...

New USFDA guidance to benefit Indian Pharma Companies

Indian pharma industry is of the view that the recent USFDA guidance on ANDA (abbreviated new drug application) submissions, amendments and requests...

‘Buy US-made meds’ order may hurt desi pharma companies

MUMBAI: US President Donald Trump’s order directing his government to increase procurement of indigenously-manufactured essential medicines, could hurt Indian Generic pharmaceutical companies once implemented, though there may not be...

Incentives to desi firms to cut dependence on China’s APIs

NEW DELHI: With an aim to reduce its import dependence on China for sourcing drug raw material and spur production in India, the government proposes...

ICRA upgrades Pharma Cos as China reopens

ICRA upgrades Pharma Companies as China reopens Mumbai: As China restarts manufacturing activity, including for pharmaceutical raw material, rating agency ICRA has revised...

Indian pharma Cos will play imp role in fight against COVID-19

Indian pharmaceutical companies, the well-known for producing affordable low-cost medicines, will play an important role in the global fight against the coronavirus pandemic that...

अमेरिका ने भारत की 4 प्रमुख दवा कंपनियों को दी मंजूरी

मुंबई। अमेरिका के फूड एंड ड्रग एडमिनिस्ट्रेटर (USFDA) ने भारत की चार प्रमुख फार्मा कंपनियों को उनकी मैन्युफैक्चरिंग फैसिलिटी के लिए मंजूरी दी...

World pharma supplier India restricts export of 26 APIs, drugs

BENGALURU/NEW DELHI: India, the world's main supplier of generic drugs, on Tuesday restricted the export of 26 pharmaceutical ingredients and drugs made...

Opportunity for select domestic pharma firms

New Delhi: The biosimilars global market is on the cusp of exceptional growth and presents attractive opportunities for select domestic pharmaceutical companies in the years to...

खून पतला करने वाली दवा हुई सस्ती

ग्वालियर। डायबिटीज और हार्ट पेशेंट को जिन दवाओं के लिए अधिक पैसे खर्च करने पड़ते थे, वह अब उन्हें कम कीमत में...

Latest posts

NPPA fixes retail price of 2 formulations: November 2021

Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of two (2) formulations under the Drugs (Prices Control)...

Authors

59 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS